AlzChem Group AG
ALZCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $576 | $254 | $262 | $247 |
| - Cash | $62 | $12 | $9 | $8 |
| + Debt | $53 | $62 | $100 | $56 |
| Enterprise Value | $567 | $305 | $353 | $294 |
| Revenue | $554 | $541 | $542 | $422 |
| % Growth | 2.5% | -0.3% | 28.4% | – |
| Gross Profit | $361 | $299 | $283 | $268 |
| % Margin | 65.1% | 55.3% | 52.1% | 63.5% |
| EBITDA | $107 | $82 | $70 | $63 |
| % Margin | 19.4% | 15.1% | 12.9% | 14.8% |
| Net Income | $54 | $35 | $30 | $28 |
| % Margin | 9.8% | 6.4% | 5.5% | 6.5% |
| EPS Diluted | 5.31 | 3.4 | 2.97 | 2.72 |
| % Growth | 56.2% | 14.5% | 9.2% | – |
| Operating Cash Flow | $105 | $73 | -$4 | $43 |
| Capital Expenditures | -$43 | -$21 | -$29 | -$29 |
| Free Cash Flow | $105 | $52 | -$33 | $14 |